Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Age ≥18 Years”

1,371 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,371 results

Not applicableStudy completedNCT01622959
What this trial is testing

Use of ACUPUNCTURE in Emergency Departement

Who this might be right for
Age ≥18 YearsPresigned Consentement to Participate in the Study
University of Monastir 300
Early research (Phase 1)Study completedNCT03213405
What this trial is testing

Assess Safety, Tolerability and Immunogenicity of the Live Attenuated hRSV Vaccine rBCG-N-hRSV

Who this might be right for
Respiratory Syncytial Virus Infections
Pontificia Universidad Catolica de Chile 24
Post-approval studies (Phase 4)UnknownNCT00378729
What this trial is testing

Surgical Ovarian Drilling Versus Hormonal Treatment for Infertility Associated to PolyCystic Ovaries Syndrome (PCOS)

Who this might be right for
Polycystic Ovary Syndrome
Assistance Publique - Hôpitaux de Paris 252
Large-scale testing (Phase 3)Study completedNCT05047770
What this trial is testing

A Study on the Immune Response and Safety of the Shingles Vaccine and the Influenza Vaccine When Either is Given to Healthy Adults at the Same Time or Following a COVID-19 Booster Vaccine

Who this might be right for
Herpes Zoster
GlaxoSmithKline 2,013
Large-scale testing (Phase 3)Study completedNCT04652102
What this trial is testing

A Phase 2b/3, Randomized, Observer-Blinded, Placebo-Controlled, Multicenter Clinical Study Evaluating the Efficacy and Safety of Investigational SARS-CoV-2 mRNA Vaccine CVnCoV in Adults 18 Years of Age and Older

Who this might be right for
Covid19SARS-CoV-2
CureVac 39,680
Large-scale testing (Phase 3)Study completedNCT04754594
What this trial is testing

To Evaluate the Safety, Tolerability, and Immunogenicity of BNT162b2 Against COVID-19 in Healthy Pregnant Women 18 Years of Age and Older

Who this might be right for
SARS-CoV-2 InfectionCOVID-19Maternal Immunization
BioNTech SE 726
Large-scale testing (Phase 3)Study completedNCT06120751
What this trial is testing

A Clinical Trial to Evaluate the Safety and Immunogenicity of a Single Dose of Adsorbed Tetanus Vaccine in a Population Aged 18 Years and Over

Who this might be right for
Tetanus
CanSino Biologics Inc. 1,000
Testing effectiveness (Phase 2)Looking for participantsNCT07285213
What this trial is testing

Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal Antibody

Who this might be right for
Clostridioides Difficile Infection
AstraZeneca 230
Large-scale testing (Phase 3)Study completedNCT00290277
What this trial is testing

Evaluate the Immunogenicity & Safety of GSK Biologicals' HPV Vaccine in Female Subjects Aged 10-14 Years

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 300
Not applicableUnknownNCT05745545
What this trial is testing

Clinical Trial of COVID-19 Vaccine（SARS-CoV-2 Variant(Omicron BA.5) mRNA Vaccine） in Participants Aged 18 Years and Over

Who this might be right for
SARS-CoV-2
AIM Vaccine Co., Ltd. 3,200
Large-scale testing (Phase 3)Study completedNCT01998477
What this trial is testing

Evaluate the Safety of Two Influenza Vaccines in Children and Adolescents 3 to <18 Years of Age at Risk for Influenza-Related Complications

Who this might be right for
Influenza
Novartis Vaccines 430
Testing effectiveness (Phase 2)Study completedNCT02270944
What this trial is testing

Safety and Immunogenicity of the Liquid Formulation of Group B Streptococcus Trivalent Vaccine and of the Lyophilized Formulation of Group B Streptococcus Trivalent Vaccine

Who this might be right for
Infections, StreptococcalStreptococcal Infections
GlaxoSmithKline 1,053
Testing effectiveness (Phase 2)Study completedNCT05995275
What this trial is testing

Investigate The Safety, Tolerability, And Immune Response of a Range of Doses of mRNA-1769 Compared With Placebo in Healthy Participants From ≥18 Years of Age to <50 Years of Age

Who this might be right for
SmallpoxMpox
ModernaTX, Inc. 351
Not applicableStudy completedNCT03694392
What this trial is testing

Flublok v. Standard Dose Vaccine Effectiveness Among Kaiser Permanente Northern California Adults 18-64 Years

Who this might be right for
InfluenzaPneumoniaLower Respiratory Tract Infection+3 more
Kaiser Permanente 2,776,278
Not applicableStudy completedNCT01891409
What this trial is testing

Use of the Shang Ring Circumcision Device in Boys Below 18 Years Old in Kenya

Who this might be right for
Human Immunodeficiency Virus
EngenderHealth 80
Not applicableActive Not RecruitingNCT06197802
What this trial is testing

Plateau Antibody Levels of a Recombinant (E.Coli) HPV Nonavalent Vaccine Versus Gardasil®9 in Young Women

Who this might be right for
Cervical CancerCondylomata Acuminata
Xiamen University 392
Early research (Phase 1)Active Not RecruitingNCT06564194
What this trial is testing

Evaluate JCXH-108, an mRNA-based Vaccine Against RSV

Who this might be right for
Respiratory Syncytial Virus (RSV)Infectious Disease
Immorna Biotherapeutics, Inc. 75
Large-scale testing (Phase 3)WithdrawnNCT04293172
What this trial is testing

Study to Evaluate the Effect of Ticagrelor Versus Placebo in Reducing Vaso-Occlusive Crises Rate in Pediatric Patients With Sickle Cell Disease.

Who this might be right for
Sickle Cell Disease
AstraZeneca
Not applicableStudy completedNCT03503357
What this trial is testing

ConsCIOUS2 Study of the Isolated Forearm Technique Commands

Who this might be right for
Anesthesia Awareness
University of Wisconsin, Madison 344
Testing effectiveness (Phase 2)Study completedNCT01193907
What this trial is testing

Safety and Immunogenicity of Three Formulations of Vi-CRM197 Vaccine Against S. Typhi in Adults (18-40 Years Old)

Who this might be right for
Typhoid Fever
Novartis 88
Next Page